EDITAS MEDICINE, INC.

Profile

Company Names

EDITAS MEDICINE, INC.

Addresses

300 THIRD STREET, FIRST FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-401-9000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$119,999,970.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2015-08-04 
$119,999,970.00 
$119,999,970.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEVIN 
 
BITTERMAN 
DIRECTOR
PARASOL THERAPEUTICS INC   |  TARIS BIOMEDICAL INC   |  BIOLEX THERAPEUTICS, INC.   |  FOLLICA, INC   |  VISTERRA, INC.   |  KALA PHARMACEUTICALS, INC.   |  GENOCEA BIOSCIENCES, INC.   |  NEURONETICS, INC.   |  DIRECT VET MARKETING, INC.   |  EDITAS MEDICINE, INC.   |  MORPHIC HOLDING, LLC   |  ATLAS VENTURE FUND XI, L.P.   |  NAVITOR PHARMACEUTICALS, INC.   |  AKERO THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  KINASET THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  JUDO BIO INC.   |  CHROMA MEDICINE, INC.   |  REMIX THERAPEUTICS, INC.   |  GRO BIOSCIENCES INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  RENASANT BIO, INC.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
ALEXIS 
 
BORISY 
DIRECTOR
FOUNDATION MEDICINE, INC.   |  FORMA THERAPEUTICS HOLDINGS LLC   |  BLUEPRINT MEDICINES CORP   |  EDITAS MEDICINE, INC.   |  REVOLUTION MEDICINES, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  MAGENTA THERAPEUTICS, INC.   |  CELSIUS THERAPEUTICS, INC.   |  TANGO THERAPEUTICS, INC.   |  RELAY THERAPEUTICS, INC.   |  CURIE BIO SERIES A FUND I, L.P.   |  CURIE BIO SEED FUND II, L.P.   |  CURIE BIO SEED FUND II-A, L.P.
KATRINE 
 
BOSLEY 
EXECUTIVE OFFICER, DIRECTOR
AVILA THERAPEUTICS INC   |  GENOCEA BIOSCIENCES, INC.   |  EDITAS MEDICINE, INC.   |  SCHOLAR ROCK LLC
DOUGLAS 
 
COLE 
DIRECTOR
AVEO PHARMACEUTICALS INC   |  TETRAPHASE PHARMACEUTICALS INC   |  RESOLVYX PHARMACEUTICALS, INC.   |  SELECTA BIOSCIENCES INC   |  QUANTERIX CORP   |  LS22, INC.   |  SYROS PHARMACEUTICALS, INC.   |  EDITAS MEDICINE, INC.   |  SANA BIOTECHNOLOGY, INC.
ALEXANDRA 
 
GLUCKSMANN 
EXECUTIVE OFFICER
CERULEAN PHARMA INC.   |  EDITAS MEDICINE, INC.   |  CEDILLA THERAPEUTICS, INC.   |  SENSORIUM THERAPEUTICS, INC.
ANDREW 
 
HACK 
EXECUTIVE OFFICER
EDITAS MEDICINE, INC.   |  JENAVALVE TECHNOLOGY INC   |  IMPERATIVE CARE, INC.   |  AFFINIVAX, INC.   |  XILIO THERAPEUTICS, INC.   |  NUVALENT, INC.
VIC 
 
MYER 
EXECUTIVE OFFICER
EDITAS MEDICINE, INC.   |  KROMATID, INC.   |  CHROMA MEDICINE, INC.
BORIS 
 
NIKOLIC 
DIRECTOR
BLUE TALON DATA SYSTEMS, INC.   |  BLUETALON, INC.   |  EDITAS MEDICINE, INC.   |  BIOMATICS CAPITAL PARTNERS, L.P.   |  EGENESIS, INC.   |  GUIDE THERAPEUTICS, INC.   |  BIOINTEL VENTURE FUND, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-08-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#